Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-59.70M.
ENTERPRISE VALUE (EV)
$-59.70M
XBiotech Inc.
Market Cap
$65.85M
Enterprise Value (EV)
$-59.70M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| XBiotech Inc. (XBIT) | $65.85M | $-59.70M |
| Cingulate Inc. (CING)vs › | $65.86M | $43.75M |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | $63.83M |
| iBio, Inc. (IBIO)vs › | $67.52M | $13.33M |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | $67.64M |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | $105.87M |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | $20.17M |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | $190.42M |
Market Cap
$65.85M
Total Debt
$0.00
Cash
$125.55M
Enterprise Value
$-59.70M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
